Close Menu

NEW YORK (GenomeWeb) – Biocept reported Monday after the close of the market a year-over-year increase in second quarter revenues and commercial testing business volume, but also a higher net loss compared to the previous year.

Separately today, the firm announced a new collaboration with the University of California, Irvine to evaluate its liquid biopsy platform in guiding treatment for metastatic cancer patients.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.